AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT FOR INVESTORSRegistration Rights Agreement • February 2nd, 2021 • Movano Inc. • Electromedical & electrotherapeutic apparatus • New York
Contract Type FiledFebruary 2nd, 2021 Company Industry JurisdictionTHIS AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is effective as of March 28, 2019 by and among Movano Inc., a Delaware corporation (“Company”), and the persons listed on Schedule A hereto, referred to individually as the “Stockholder” and collectively as the “Stockholders”.
REGISTRATION RIGHTS AGREEMENT FOR INVESTORSRegistration Rights Agreement • February 2nd, 2021 • Movano Inc. • Electromedical & electrotherapeutic apparatus • New York
Contract Type FiledFebruary 2nd, 2021 Company Industry JurisdictionTHIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made as of [_____], 2018, by and among Maestro Sensors Inc., a Delaware corporation (“Company”), and the persons listed on Schedule A hereto, referred to individually as the “Stockholder” and collectively as the “Stockholders”.
AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT FOR INVESTORSRegistration Rights Agreement • August 20th, 2019 • TFF Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledAugust 20th, 2019 Company Industry JurisdictionTHIS AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made as of May 16, 2019, by and among TFF Pharmaceuticals, Inc., a Delaware corporation (“Company”), and the persons listed on Schedule A hereto, referred to individually as the “Stockholder” and collectively as the “Stockholders”.
REGISTRATION RIGHTS AGREEMENT FOR INVESTORSRegistration Rights Agreement • October 11th, 2018 • TFF Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledOctober 11th, 2018 Company Industry JurisdictionTHIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made as of March 13, 2018, by and among TFF Pharmaceuticals, Inc., a Delaware corporation (“Company”), and the persons listed on Schedule A hereto, referred to individually as the “Stockholder” and collectively as the “Stockholders”.
REGISTRATION RIGHTS AGREEMENT FOR INVESTORSRegistration Rights Agreement • August 10th, 2018 • Eton Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledAugust 10th, 2018 Company Industry JurisdictionTHIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made as of June 19, 2017,1 by and among Eton Pharmaceuticals, Inc., a Delaware corporation (“Company”), and the persons listed on Schedule A hereto, referred to individually as the “Stockholder” and collectively as the “Stockholders”.
REGISTRATION RIGHTS AGREEMENT FOR INVESTORSRegistration Rights Agreement • June 28th, 2018 • Eton Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJune 28th, 2018 Company Industry JurisdictionTHIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made as of June 19, 2017,1 by and among Eton Pharmaceuticals, Inc., a Delaware corporation (“Company”), and the persons listed on Schedule A hereto, referred to individually as the “Stockholder” and collectively as the “Stockholders”.
REGISTRATION RIGHTS AGREEMENT FOR INVESTORSRegistration Rights Agreement • March 20th, 2018 • Eton Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 20th, 2018 Company Industry JurisdictionTHIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made as of June 19, 2017,1 by and among Eton Pharmaceuticals, Inc., a Delaware corporation (“Company”), and the persons listed on Schedule A hereto, referred to individually as the “Stockholder” and collectively as the “Stockholders”.